| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


( Department of Anatomy, State University of New York, College of Medicine at New York City, Brooklyn, New York)
Tumor-bearing C3H mice were injected with I131-labeled triiodothyronine and sacrificed at 1, 4, and 8 hours later. The I131-labeled compounds in mammary tumors, mammary gland, muscle, and plasma were separated by paper chromatography.
During the course of this work a previously unidentified contaminant, in the triiodothyronine solution, was identified as 3,3'-diiodothyronine on paper chromatographic evidence.
Triiodothyronine accounted for most of the organic I131 in the tissues and was accompanied by various amounts of iodide. In addition, a compound tentatively identified as 3,3'-diiodothyronine accounted for 10 per cent of the activity in plasma and tumors, and for 45 per cent in muscle and mammary gland.
* This investigation was supported by a grant from the United States Atomic Energy Commission under their contract No. At (30-1)-1760.
Present address: Department of Physics, Memorial Center, New York, N.Y.
Present address: Experimental Medicine and Cancer Research, Hebrew University, Hadassah Medical School, Jerusalem, Israel.
Received 10/21/59.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |